(Received for publication September 30, 1993) In a previous communication1} we described analogues of cefotaxime (1) in which the C-3 acetoxymethyl group was replaced by a lactone (2) .
In our search for additional metabolically stable analogues, and encouraged by reports of some C-2 substituted penems2), we targeted the C-3 cyclic ether cephems (3, n=\, 2) . Our synthesis adopted, in modified form, the Wittig cyclisation chemistry of Woodwardet al.3) and Nayler et al.4) (Scheme 1). The racemic acids (4) were converted in conventional fashion into the corresponding chloromethyl ketones (5), which were then used to alkylate the azetidinone thiol5) (6). Addition of^-butyl glyoxylate to the derived ketone (7), followed by elaboration of the aminols (8) with thionyl chloride and 2,6-lutidine then tri-w-butylphosphine, provided the phosphoranes (9). On thermolysis in refluxing toluene these phosphoranes cleanly cyclised to the cephems (10) in high yields. As reported for the lactonyl derivatives1}, the use of tri-rc-butyl phosphoranes in place of the triphenyl analogues was advantageous, the latter requiring prolonged reaction times or increased temperatures (thermolysis in xylene) resulting in greatly reduced yields. In was obtained from both enantiomerically pure intermediates (14a and 14b). The sodium salts were alkylated with iodomethyl pivalate to provide the pivaloyloxymethyl prodrug esters (15) for oral absorption studies. The antibacterial activities of the sodium salts (3) (Table 1) show that the tetrahydrofuran (3, n-\) was significantly more potent than the tetrahydropyranyl analogue (3, n=2) against several strains, and although it did not match the C-3 lactonyl analogues1*, compared favourably with cefuroxime, and cefetamet. The oral absorption of the pivaloyloxymethyl prodrug esters (15) was examined in mice and compared with the a-acetoxyethyl ester of cefuroxime (cefuroxime axetil8)) and the pivaloyloxymethyl ester of cefetamet (cefetamet pivoxil9)). The results ( Table 2 ) dramatically demonstrate that the C-3 cyclic ether cephems give vastly superior AUCs, peak concentrations in blood (Cmax) and half lives whencomparedto the standard compounds.
While this manuscript was in preparation, the preparation of a C-3 (3-bromotetrahydrofuran-2-yl)cephem was Following oral administration of esters (15) at a dose equivalent to 50mg-kg x of antibiotic (3).
AUCof prodrug ester (po) AUCof parent cephem (sc)
x lOO.
[HPLCresults] Concentrations of antibiotic in blood measured by bioassay and confirmed by HPLC for (3, n=l). (3, n=\) has been identified as an analogue of cefotaxime which is well absorbed in the mouse as its pivaloyloxymethyl prodrug ester (15, n= 1) and gives high and prolonged levels of antibiotic in the blood and is worthy of further studies.
